(Q44931333)

7 December 2017

title

Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France (English)

1 reference

7 December 2017

Baudouin Standaert

1

1 reference

7 December 2017

Nathalie Parez

2

1 reference

7 December 2017

Bertrand Tehard

3

1 reference

7 December 2017

Xavier Colin

4

1 reference

7 December 2017

Bruno Detournay

5

1 reference

7 December 2017

publication date

1 January 2008

1 reference

Applied Health Economics and Health Policy

7 December 2017

published in

1 reference

7 December 2017

volume

6

1 reference

7 December 2017

issue

4

1 reference

7 December 2017

page(s)

199-216

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03256134

7 December 2017

exact match

0 references

cites work

Global Illness and Deaths Caused by Rotavirus Disease in Children

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Burden of rotavirus disease in European Union countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Rotavirus infection in infants as protection against subsequent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

[Morbidity and cost of rotavirus infections in France]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Estimating utility scores in young children with acute rotavirus gastroenteritis in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Vaccines for rotavirus gastroenteritis universally needed for infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Acute gastro-enteritis in children in France: estimates of disease burden through national hospital discharge data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Role of human-milk lactadherin in protection against symptomatic rotavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Discounting health effects in pharmacoeconomic evaluations: current controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

The practice of discounting in economic evaluations of healthcare interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Discounting and health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Economic notes. Discounting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Nosocomial viral infections in a pediatric service: example of rotaviral gastroenteritis and respiratory syncytial viral bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Cost and cost-effectiveness of childhood vaccination against rotavirus in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

Cost-effectiveness and potential impact of rotavirus vaccination in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256134

21 January 2018

Identifiers

DOI

10.1007/BF03256134

1 reference

7 December 2017

1 reference